Atherothrombosis as a systematic, often silent, disease

In summary, physicians need to approach all manifestations of AVD, whether clinically symptomatic or silent, as one pathologic entity that intermittently affects different vascular territories. This approach will result in appropriate risk stratification and therapy, reductions in future events, and a better quality of life for our patients.